These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10481844)

  • 1. Is a single dose of MDMA harmless?
    Vollenweider FX; Gamma A; Liechti M; Huber T
    Neuropsychopharmacology; 1999 Oct; 21(4):598-600. PubMed ID: 10481844
    [No Abstract]   [Full Text] [Related]  

  • 2. Caveat emptor: editors beware.
    McCann UD; Ricaurte GA
    Neuropsychopharmacology; 2001 Mar; 24(3):333-6. PubMed ID: 11256359
    [No Abstract]   [Full Text] [Related]  

  • 3. MDMA study.
    Gijsman HJ; Verkes RJ; van Gerven JM; Cohen AF
    Neuropsychopharmacology; 1999 Oct; 21(4):597. PubMed ID: 10481843
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ecstasy is a dangerous drug the society chooses to ignore].
    Heilig M
    Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555
    [No Abstract]   [Full Text] [Related]  

  • 5. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA and serotonin: based on two cases.
    Garcia Cabeza I; Zabala A; Soto-Montenegro ML; Arango C
    Actas Esp Psiquiatr; 2005; 33(5):339-42. PubMed ID: 16155817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.
    Uys JD; Niesink RJ
    Drug Alcohol Rev; 2005 Jul; 24(4):359-68. PubMed ID: 16234132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
    Kish SJ
    Mov Disord; 2003 Nov; 18(11):1219-23. PubMed ID: 14639660
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroscience. Drug find could give ravers the jitters.
    Holden C
    Science; 2002 Sep; 297(5590):2185-7. PubMed ID: 12351758
    [No Abstract]   [Full Text] [Related]  

  • 10. More about parkinsonism after taking ecstasy.
    Borg GJ
    N Engl J Med; 1999 Oct; 341(18):1400; author reply 1401. PubMed ID: 10577095
    [No Abstract]   [Full Text] [Related]  

  • 11. Ecstasy and neurodegeneration.
    Green AR; Goodwin GM
    BMJ; 1996 Jun; 312(7045):1493-4. PubMed ID: 8646128
    [No Abstract]   [Full Text] [Related]  

  • 12. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is the anxiety about Ecstasy justified?].
    Möller-Nehring E; Luderer HJ
    Fortschr Med; 1997 Mar; 115(7):28, 31-2, 34. PubMed ID: 9173018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12):574-6. PubMed ID: 10683753
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of ecstasy on the body].
    Saarijärvi S; Lopperi M
    Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors.
    Rodríguez-Arias M; Valverde O; Daza-Losada M; Blanco-Gandía MC; Aguilar MA; Miñarro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():77-84. PubMed ID: 23959085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography findings in heavy users of MDMA.
    Holland J
    Lancet; 1999 Feb; 353(9152):592-3. PubMed ID: 10029009
    [No Abstract]   [Full Text] [Related]  

  • 18. MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press.
    Green AR
    Psychopharmacology (Berl); 2004 May; 173(3-4):231-3. PubMed ID: 14985917
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.
    McCoy EP; Renfrew C; Johnston JR; Lavery G
    Ulster Med J; 1994 Apr; 63(1):103-7. PubMed ID: 8658983
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial note: MDMA-induced dopamine neurotoxicity.
    Warburton DM
    Psychopharmacology (Berl); 2004 Jan; 171(2):228. PubMed ID: 14634718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.